A Study to Evaluate the Efficacy and Safety of TF0023 Spray on Subjects With Ischemic Strokes

A phase 2 trial registered on ClinicalTrials.gov. The registry status is suspended. It plans to enroll 225 participants.

Also called NCT02785120

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 225 participants (planned count) (from the registry)
Sponsor
Techfields Inc (from the registry)
Registry
  • NCT NCT02785120
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Suspended (from the registry)

Technical summary

Registry record NCT02785120. Randomized; triple masking; primary purpose treatment. Start 2017-03-01 (actual); primary completion 2024-10 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study to Evaluate the Efficacy and Safety of TF0023 Spray on Subjects With Ischemic Strokes
Acronym
TF0023
Intervention (Drug)
TF0023
Lead sponsor
Techfields Inc (class: industry)

Record details

Record id
cardio:ct-nct02785120
Content hash
8e846642ad604eea047b26630adc63a456d748ed538b3d14c4817ee0802c52f0